Literature DB >> 15056087

A genomewide screen in a four-generation Dutch family with celiac disease: evidence for linkage to chromosomes 6 and 9.

Martine J van Belzen1, Martine M Vrolijk, Jos W R Meijer, J Bart A Crusius, Peter L Pearson, Lodewijk A Sandkuijl, Roderick H J Houwen, Cisca Wijmenga.   

Abstract

OBJECTIVES: Celiac disease is caused by the interaction of multiple genes and environmental factors. Inheritance of the disease shows a complex pattern with a 10% sibling recurrence risk. The HLA-region is a major genetic risk locus in celiac disease, but genes outside this region are expected to contribute to the disease risk as well. The aim of this study was to identify the loci causing celiac disease in one large Dutch family with apparent dominant transmission of the disease.
METHODS: The family comprised 17 patients in four generations, with possible transmission of the disease by both grandparents. Microsatellite markers evenly spread over all chromosomes were genotyped and linkage analysis was performed using both dominant and recessive disease models and a model-free analysis.
RESULTS: Disease susceptibility in the family was linked to the HLA-region (lod score of 2.33) and all patients were HLA-DQ2. A dominantly inherited non-HLA locus with a maximum lod score of 2.61 was detected at 9p21-13, which was shared by 16 patients. Model-free analysis identified another possible non-HLA locus, at 6q25.3, which was shared by 14 patients (p = 0.01). Neither of these regions was detected in a genomewide screen in Dutch affected sibpairs, but the 9p21 locus has been implicated in Scandinavian families.
CONCLUSIONS: Two potential non-HLA loci for celiac disease were identified in this large Dutch family. Our results provide replication of the Scandinavian 9p21 locus, and suggest that this locus plays a role in celiac disease patients from different Caucasian populations.

Entities:  

Mesh:

Year:  2004        PMID: 15056087     DOI: 10.1111/j.1572-0241.2004.04072.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

Review 1.  Gluten: a two-edged sword. Immunopathogenesis of celiac disease.

Authors:  Frits Koning; Luud Gilissen; Cisca Wijmenga
Journal:  Springer Semin Immunopathol       Date:  2005-08-10

Review 2.  Celiac disease: pathogenesis of a model immunogenetic disease.

Authors:  Martin F Kagnoff
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Meta-analysis of genome-wide linkage studies in celiac disease.

Authors:  Paola Forabosco; Susan L Neuhausen; Luigi Greco; Asa Torinsson Naluai; Cisca Wijmenga; Paivi Saavalainen; Richard S Houlston; Paul J Ciclitira; Marie-Claude Babron; Cathryn M Lewis
Journal:  Hum Hered       Date:  2009-07-22       Impact factor: 0.444

4.  Celiac disease and HLA in a Bedouin kindred.

Authors:  Elise Eller; Pnina Vardi; Sunanda R Babu; Teodorica L Bugawan; Henry A Erlich; Liping Yu; Pamela R Fain
Journal:  Hum Immunol       Date:  2006-09-18       Impact factor: 2.850

5.  Multiple independent variants in 6q21-22 associated with susceptibility to celiac disease in the Dutch, Finnish and Hungarian populations.

Authors:  Elisabet Einarsdottir; Marianna R Bevova; Alexandra Zhernakova; Alienke Monsuur; Lotta L E Koskinen; Ruben van't Slot; Chris Mulder; M Luisa Mearin; Ilma R Korponay-Szabo; Katri Kaukinen; Kalle Kurppa; Juha Kere; Markku Mäki; Cisca Wijmenga; Päivi Saavalainen
Journal:  Eur J Hum Genet       Date:  2011-02-16       Impact factor: 4.246

Review 6.  Tipping the balance: inhibitory checkpoints in intestinal homeostasis.

Authors:  Maria E Joosse; Iris Nederlof; Lucy S K Walker; Janneke N Samsom
Journal:  Mucosal Immunol       Date:  2018-11-29       Impact factor: 7.313

7.  The SPINK gene family and celiac disease susceptibility.

Authors:  Martin C Wapenaar; Alienke J Monsuur; Jos Poell; Ruben van 't Slot; Jos W R Meijer; Gerrit A Meijer; Chris J Mulder; Maria Luisa Mearin; Cisca Wijmenga
Journal:  Immunogenetics       Date:  2007-02-27       Impact factor: 2.846

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.